Patents by Inventor Peter Kane

Peter Kane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12157742
    Abstract: Pharmaceutical compositions of the invention comprise kinase inhibitors having a disease-modifying action in the treatment of diseases associated with BCR-ABL activity that include cancer, including chronic myeloid leukemia, acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, multiple myeloma, lymphomas, and metastatic carcinoma.
    Type: Grant
    Filed: May 31, 2023
    Date of Patent: December 3, 2024
    Assignee: Allcron Pharma Inc.
    Inventors: Ayyappan Rajasekaran, Jon Swanson, Peter Kane, Julia Foster
  • Publication number: 20230399337
    Abstract: Pharmaceutical compositions of the invention comprise kinase inhibitors having a disease-modifying action in the treatment of diseases associated with BCR-ABL activity that include cancer, including chronic myeloid leukemia, acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, multiple myeloma, lymphomas, and metastatic carcinoma.
    Type: Application
    Filed: May 31, 2023
    Publication date: December 14, 2023
    Inventors: Ayyappan RAJASEKARAN, Jon SWANSON, Peter KANE, Julia FOSTER
  • Patent number: 11697654
    Abstract: Pharmaceutical compositions of the invention comprise kinase inhibitors having a disease-modifying action in the treatment of diseases associated with BCR-ABL activity that include cancer, including chronic myeloid leukemia, acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, multiple myeloma, lymphomas, and metastatic carcinoma.
    Type: Grant
    Filed: March 18, 2019
    Date of Patent: July 11, 2023
    Assignee: ALLCRON PHARMA INC.
    Inventors: Ayyappan Rajasekaran, Jon Swanson, Peter Kane, Julia Foster
  • Publication number: 20210040104
    Abstract: Pharmaceutical compositions of the invention comprise kinase inhibitors having a disease-modifying action in the treatment of diseases associated with BCR-ABL activity that include cancer, including chronic myeloid leukemia, acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, multiple myeloma, lymphomas, and metastatic carcinoma.
    Type: Application
    Filed: March 18, 2019
    Publication date: February 11, 2021
    Inventors: Ayyappan RAJASEKARAN, Jon SWANSON, Peter KANE, Julia FOSTER
  • Patent number: 10789973
    Abstract: According to one aspect, driver management is provided. One or more speech segments of a driver of an autonomous vehicle may be recorded. A position, a destination, or a previous destination of a driver or an autonomous vehicle may be tracked. An estimated state of the driver may be determined based on one or more of the speech segments, the position, the destination, or the previous destination, and a calendar event associated with the driver or a passenger of the autonomous vehicle. Autonomous driving features may be automatically enabled, disabled, or operation of the autonomous vehicle may be enabled or disabled in different modes based on the estimated state of the driver. Additionally, notifications may be displayed, rideshare applications may be launched, or warnings may be sent based on the estimated state of the driver.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: September 29, 2020
    Assignee: HONDA MOTOR CO., LTD.
    Inventors: Adrian Peters Kane, Robert Wesley Murrish, Shuhei Kinoshita, Wonravee Chavalit
  • Publication number: 20200075043
    Abstract: According to one aspect, driver management is provided. One or more speech segments of a driver of an autonomous vehicle may be recorded. A position, a destination, or a previous destination of a driver or an autonomous vehicle may be tracked. An estimated state of the driver may be determined based on one or more of the speech segments, the position, the destination, or the previous destination, and a calendar event associated with the driver or a passenger of the autonomous vehicle. Autonomous driving features may be automatically enabled, disabled, or operation of the autonomous vehicle may be enabled or disabled in different modes based on the estimated state of the driver. Additionally, notifications may be displayed, rideshare applications may be launched, or warnings may be sent based on the estimated state of the driver.
    Type: Application
    Filed: August 28, 2018
    Publication date: March 5, 2020
    Inventors: Adrian Peters Kane, Robert Wesley Murrish, Shuhei Kinoshita, Wonravee Chavalit
  • Publication number: 20190355352
    Abstract: A conversation recognition system on board a vehicle includes an acoustic sensor component that detects sound in a cabin of the vehicle, a voice recognition component coupled to the acoustic sensor component that analyzes the sound detected by the acoustic sensor component and identifies a plurality of utterances, and a conversation threading unit coupled to the voice recognition component that analyzes the utterances identified by the voice recognition component and identifies a plurality of conversations between a plurality of occupants of the vehicle. The conversation recognition system enables multiple conversations in an environment to be recognized and distinguished from each other.
    Type: Application
    Filed: May 18, 2018
    Publication date: November 21, 2019
    Inventors: Adrian Peters Kane, Robert Wesley Murrish, Shuhei Kinoshita, Wonravee Chavalit
  • Patent number: 9841296
    Abstract: A rotary position sensor includes a member with a shaft associated with the member such that movement of the member rotates the shaft. An arc-shaped permanent magnet is coupled to a periphery of the shaft for rotation therewith. First and second adjacent magnetic field concentrators define a gap there-between. Sensor structure is disposed in the gap. Upon movement of the member causing rotation of the shaft and magnet, the concentrators and sensor structure remain stationary, with the magnet providing a magnetic pole that changes the magnetic field in the gap. The sensor structure is constructed and arranged to respond to the changes in the magnetic field to identify a position of the member.
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: December 12, 2017
    Assignee: Continental Automotive Systems, Inc.
    Inventors: Peter Kane, John Lackey
  • Publication number: 20130063134
    Abstract: A rotary position sensor includes a member with a shaft associated with the member such that movement of the member rotates the shaft. An arc-shaped permanent magnet is coupled to a periphery of the shaft for rotation therewith. First and second adjacent magnetic field concentrators define a gap there-between. Sensor structure is disposed in the gap. Upon movement of the member causing rotation of the shaft and magnet, the concentrators and sensor structure remain stationary, with the magnet providing a magnetic pole that changes the magnetic field in the gap. The sensor structure is constructed and arranged to respond to the changes in the magnetic field to identify a position of the member.
    Type: Application
    Filed: April 6, 2011
    Publication date: March 14, 2013
    Applicant: CONTINENTAL AUTOMOTIVE SYSTEMS, INC.
    Inventors: Peter Kane, John Lackey
  • Patent number: 7723358
    Abstract: The present invention relates to derivatives of aroyl-O-piperidine structure of the general formula (I): in which R1, R2, R3 and R4 are as defined in the description. Application of the compounds of the formula (I) to the treatment of hyper-triglyceridaemia, hypercholesterolaemia and dyslipidaemia, and to the prevention or treatment of obesity.
    Type: Grant
    Filed: May 19, 2005
    Date of Patent: May 25, 2010
    Assignee: Merck Patent GmbH
    Inventors: Philippe Guedat, Francois Collonges, Olivier Chevreuil, Hervé Dumas, Marie Noelle Denault, Stéphane Yvon, Peter Kane, Julia Lainton, Avril Robertson, Bernd Wendt
  • Patent number: 7674803
    Abstract: The present invention relates to thiazolylpiperidine derivatives of the general formula (I): in which: A represents a radical chosen from the radicals a1 and a2 below: G represents a bond or a divalent radical chosen from the groups g1, g2 and g3 below: and R1, R2, R2?, R3, R4, R5, Y and Z are as defined in the description. Application of the compounds of the formula (I) to the treatment of hypertriglyceridaemia, hypercholesterolaemia and dyslipidaemia.
    Type: Grant
    Filed: June 2, 2004
    Date of Patent: March 9, 2010
    Assignee: Merck Patent GmbH
    Inventors: Philippe Guèdat, Francois Collonges, Hervé Dumas, Jean-Yves Ortholand, Jacques Decerprit, Jaxques Barbanton, Robert J. Foster, Peter Kane, Bernd Went
  • Publication number: 20070254919
    Abstract: The present invention relates to derivatives of aroyl-O-piperidine structure of the general formula (I): in which R1, R2, R3 and R4 are as defined in the description. Application of the compounds of the formula (I) to the treatment of hyper-triglyceridaemia, hypercholesterolaemia and dyslipidaemia, and to the prevention or treatment of obesity.
    Type: Application
    Filed: May 19, 2005
    Publication date: November 1, 2007
    Inventors: Philippe Guedat, Francois Collonges, Olivier Chevreuil, Herve Dumas, Marie Denault, Stephane Yvon, Peter Kane, Julia Lainton, Avril Robertson, Bernd Wendt
  • Publication number: 20070054939
    Abstract: The present invention relates to thiazolylpiperidine derivatives of the general formula (I): in which: A represents a radical chosen from the radicals a1 and a2 below: G represents a bond or a divalent radical chosen from the groups g1, g2 and g3 below: and R1, R2, R2?, R3, R4, R5, Y and Z are as defined in the description. Application of the compounds of the formula (I) to the treatment of hypertriglyceridaemia, hypercholesterolaemia and dyslipidaemia.
    Type: Application
    Filed: June 2, 2004
    Publication date: March 8, 2007
    Inventors: Philippe Guedat, Francois Collonges, Herve Dumas, Jean-Yves Ortholand, Jacques Decerprit, Jaxques Barbanton, Robert Foster, Peter Kane, Bernd Went
  • Publication number: 20060058372
    Abstract: The present invention relates to a compound of the formula (I): in which T, A, R, B Xi, Yi and n are as defined in Claim 1, and to the pharmaceutically usable derivatives, solvates and stereoisomers thereof, comprising a mixture thereof in all proportions, which can be used in the treatment of dyslipidaemia, and to pharmaceutical compositions comprising them.
    Type: Application
    Filed: October 1, 2003
    Publication date: March 16, 2006
    Inventors: Herve Dumas, Jacques Barbanton, Francois Collonges, Jacques Decerprit, Jean-Yves Ortholand, David Benzies, Stuart Cameron, Richard Foster, Stefan Guessregen, Peter Kane, Julia Lainton, Avril Robertson, Bernd Wendt, Mark Warne
  • Patent number: 6094960
    Abstract: A device for bending strips of metal includes a pair of cooperating holding strips adjustably mounted on a support platform. A plate orienting means selectively positions the holding plates with respect to each other, allowing the plates to hold a metal strip during the bending process. An tapered press wedge is rotatably mounted on the support platform and cooperates with the holding plates to allow operator-controlled bending of the strip secured by the holding plates. An articulation handle incorporated into the press wedge allows an operator to produce the leverage sufficient to bend the strip. The device allows an operator to make either a single bend or a series of bends with equal ease.
    Type: Grant
    Filed: April 20, 1999
    Date of Patent: August 1, 2000
    Inventors: Kevin Alan Kane, David Peter Kane